Luca Masucci

8.5k total citations · 1 hit paper
86 papers, 2.8k citations indexed

About

Luca Masucci is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Luca Masucci has authored 86 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 46 papers in Infectious Diseases, 34 papers in Epidemiology and 33 papers in Molecular Biology. Recurrent topics in Luca Masucci's work include Clostridium difficile and Clostridium perfringens research (37 papers), Gut microbiota and health (27 papers) and Microscopic Colitis (21 papers). Luca Masucci is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (37 papers), Gut microbiota and health (27 papers) and Microscopic Colitis (21 papers). Luca Masucci collaborates with scholars based in Italy, United Kingdom and United States. Luca Masucci's co-authors include Maurizio Sanguinetti, Giovanni Cammarota, Gianluca Ianiro, Antonio Gasbarrini, Stefano Bibbò, Gianluca Quaranta, Franco Scaldaferri, Guido Costamagna, Giorgia Dinoi and Loris Riccardo Lopetuso and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Luca Masucci

83 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection

2015 434 citations Giovanni Cammarota, Luca Masucci et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Luca Masucci Italy	26	1.3k	1.3k	814	569	509	86	2.8k
Alexa R. Weingarden United States	14	1.5k 1.1×	1.7k 1.3×	757 0.9×	408 0.7×	685 1.3×	26	2.6k
Anne Vrieze Netherlands	2	2.0k 1.5×	1.6k 1.2×	1.0k 1.2×	443 0.8×	725 1.4×	2	2.7k
Dina Kao Canada	32	2.1k 1.6×	2.2k 1.7×	1.2k 1.4×	829 1.5×	869 1.7×	86	3.8k
Ting Zhang China	30	1.3k 1.0×	1.3k 1.0×	813 1.0×	302 0.5×	446 0.9×	167	2.9k
Mark Smith United States	25	1.4k 1.0×	1.9k 1.5×	1.0k 1.2×	651 1.1×	569 1.1×	70	3.6k
Samuel P. Costello Australia	23	1.1k 0.8×	1.1k 0.9×	724 0.9×	434 0.8×	525 1.0×	65	2.2k
Filippo Canducci Italy	29	1.1k 0.9×	1.2k 1.0×	843 1.0×	747 1.3×	386 0.8×	79	3.5k
Mohammed Nabil Quraishi United Kingdom	19	1.1k 0.8×	2.0k 1.6×	676 0.8×	504 0.9×	534 1.0×	63	3.3k
Christine H. Lee Canada	16	2.2k 1.7×	1.8k 1.4×	1.2k 1.5×	499 0.9×	954 1.9×	34	3.1k
Enmoore Lin Australia	24	1.0k 0.8×	1.4k 1.1×	589 0.7×	295 0.5×	408 0.8×	47	3.0k

Countries citing papers authored by Luca Masucci

Since Specialization

Citations

This map shows the geographic impact of Luca Masucci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Luca Masucci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Luca Masucci more than expected).

Fields of papers citing papers by Luca Masucci

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Luca Masucci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Luca Masucci. The network helps show where Luca Masucci may publish in the future.

Co-authorship network of co-authors of Luca Masucci

This figure shows the co-authorship network connecting the top 25 collaborators of Luca Masucci. A scholar is included among the top collaborators of Luca Masucci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Luca Masucci. Luca Masucci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bibbò, Stefano, Flavio De Maio, Fioravante Capone, et al.. (2025). Case Report: Fecal microbiota transplantation via capsules ameliorated clinical outcomes in a patient with multiple sclerosis. Frontiers in Immunology. 16. 1678759–1678759.

Niccolai, Elena, Ilaria Martinelli, Giulia Nannini, et al.. (2024). Amyotrophic lateral sclerosis stratification: unveiling patterns with virome, inflammation, and metabolism molecules. Journal of Neurology. 271(7). 4310–4325. 6 indexed citations

Leibovitzh, Haim, Chen Sarbagili‐Shabat, Ayal Hirsch, et al.. (2024). P1203 Fecal transplantation for Ulcerative Colitis from diet conditioned donors followed by dietary intervention results in favorable gut microbial profile and decreased gut inflammation compared to fecal transplantation alone. Journal of Crohn s and Colitis. 18(Supplement_1). i2128–i2128. 2 indexed citations

Porcari, Serena, Sebastiano Buti, Giuseppe Fornarini, et al.. (2024). LBA77 Fecal microbiota transplantation (FMT) versus placebo in patients receiving pembrolizumab plus axitinib for metastatic renal cell carcinoma: Preliminary results of the randomized phase II TACITO trial. Annals of Oncology. 35. S1264–S1264. 24 indexed citations

Niccolai, Elena, Ilaria Martinelli, Gianluca Quaranta, et al.. (2024). Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis: Clinical Protocol and Evaluation of Microbiota Immunity Axis. Methods in molecular biology. 2761. 373–396. 9 indexed citations

Quaranta, Gianluca, Stefano Bibbò, Giovanni Cammarota, et al.. (2024). Can Gut Microbiota Analysis Reveal Clostridioides difficile Infection? Evidence from an Italian Cohort at Disease Onset. Microorganisms. 13(1). 16–16. 1 indexed citations

Quaranta, Gianluca, P. D’Argenio, I. Venturini, et al.. (2024). Donor screening for fecal microbiota transplantation with a direct stool testing-based strategy: a prospective cohort study. Microbes and Infection. 26(5-6). 105341–105341. 7 indexed citations

Ianiro, Gianluca, Benjamin H. Mullish, Tariq Iqbal, et al.. (2022). Minimising the risk of monkeypox virus transmission during faecal microbiota transplantation: recommendations from a European expert panel. The Lancet. Gastroenterology & hepatology. 7(11). 979–980. 11 indexed citations

Ianiro, Gianluca, Serena Porcari, Stefano Bibbò, et al.. (2021). Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank. Digestive and Liver Disease. 53(11). 1428–1432. 14 indexed citations

10.

Ponziani, Francesca Romana, Franco Scaldaferri, Martina De Siena, et al.. (2020). Increased Faecalibacterium abundance is associated with clinical improvement in patients receiving rifaximin treatment. Beneficial Microbes. 11(6). 519–526. 13 indexed citations

11.

Ianiro, Gianluca, Rita Murri, Giusi Desirè Sciumè, et al.. (2019). Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics. Annals of Internal Medicine. 1 indexed citations

12.

Petito, Valentina, C. Graziani, Loris Riccardo Lopetuso, et al.. (2019). Anti-tumor necrosis factor α therapy associates to type 17 helper T lymphocytes immunological shift and significant microbial changes in dextran sodium sulphate colitis. World Journal of Gastroenterology. 25(12). 1465–1477. 12 indexed citations

13.

Mandrioli, Jessica, Amedeo Amedei, Giovanni Cammarota, et al.. (2019). FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis. Frontiers in Neurology. 10. 1021–1021. 53 indexed citations

14.

Quaranta, Gianluca, Maurizio Sanguinetti, & Luca Masucci. (2019). Fecal Microbiota Transplantation: A Potential Tool for Treatment of Human Female Reproductive Tract Diseases. Frontiers in Immunology. 10. 2653–2653. 88 indexed citations

15.

Ianiro, Gianluca, Luca Valerio, Luca Masucci, et al.. (2017). Predictors of failure after single faecal microbiota transplantation in patients with recurrent Clostridium difficile infection: results from a 3-year, single-centre cohort study. Clinical Microbiology and Infection. 23(5). 337.e1–337.e3. 57 indexed citations

16.

Sterbini, Francesco Paroni, Alessandra Palladini, Luca Masucci, et al.. (2016). Effects of Proton Pump Inhibitors on the Gastric Mucosa-Associated Microbiota in Dyspeptic Patients. Applied and Environmental Microbiology. 82(22). 6633–6644. 78 indexed citations

17.

Cammarota, Giovanni, Silvia Pecere, Gianluca Ianiro, Luca Masucci, & Diego Currò. (2016). Principles of DNA-Based Gut Microbiota Assessment and Therapeutic Efficacy of Fecal Microbiota Transplantation in Gastrointestinal Diseases. Digestive Diseases. 34(3). 279–285. 27 indexed citations

18.

Masucci, Luca & Ron Goeree. (2013). Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis.. PubMed Central. 16 indexed citations

19.

Bugli, Francesca, Rosalia Graffeo, Francesco Paroni Sterbini, et al.. (2007). Monoclonal antibody fragment from combinatorial phage display library neutralizes alpha-latrotoxin activity and abolishes black widow spider venom lethality, in mice. Toxicon. 51(4). 547–554. 20 indexed citations

20.

Posteraro, Brunella, Lucio Romano, Maurizio Sanguinetti, et al.. (2000). Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method. Diagnostic Microbiology and Infectious Disease. 38(1). 29–36. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact